Michelle Solly

The Lady Who Can Tell Time. Currently Taking Care of my Chicken, I am that “fuckin Michelle on Twitter”

[Michelle Solly @MSolIender]

@steeelerheart

[Michelle Solly @MSolIender]

@BrandonJumaoas @AJFeldmanTV Yea

[Michelle Solly @MSolIender]

@lambiepie64 No they ain’t

[Michelle Solly @MSolIender]

@TraderTexMex Wrong

[Michelle Solly @MSolIender]

@FAFSA Are the $125,000 (individual)/$250,000 (household) caps based on 2021 or 2022 tax filings?

[Michelle Solly @MSolIender]

$ALT Altimmune

Insider M Scot Roberts reports selling 37,352 shares of $ALT for a total cost of $448,253.88

Insider Diane Jorkasky reports selling 17,610 shares of $ALT for a total cost of $206,943.92

[pharmacreep @pharmacreep]

$PFE $MRNA Along with Poland, it seems like Romania is also trying to get out of vaccine contracts. Expect to see many more https://t.co/qbPhiAj0EK

[Michelle Solly @MSolIender]

@kyzrrtrades $AXLA fell 37% today on no news before close, check it out

[Michelle Solly @MSolIender]

@mic_h_el @MSollender It’s a secret

[Michelle Solly @MSolIender]

@MSollender Any favorite risk / rewards here? 🐕

[Michelle Solly @MSolIender]

@MrZackMorris You don’t even know what the companies do lmao

[Michelle Solly @MSolIender]

$EPZM - Insider Legorreta Pablo G. reports buying 22,666,667 shares of for a total cost of $34,000,000.50

Insider active in the recent offering.

[Michelle Solly @MSolIender]

@MSollender Family < 3

[Michelle Solly @MSolIender]

@adamfeuerstein @damiangarde Interesting.

[Michelle Solly @MSolIender]

@MSollender Thanks for the cheapies!

[Michelle Solly @MSolIender]

@MrZackMorris and his “Index” Performance for the past week. 🩸

$TIVC -30%
$PETV -28%
$STRN -37%
$CYN -30%
$PIK -17%
$MRAI - 23%
$AHI -32%

A lot of his 500k followers blindly following blowing up their accounts.

[Michelle Solly @MSolIender]

@JLabrendola Have to raise before that.

[pharmacreep @pharmacreep]

$TGTX Funny there was this much left in the stock for CLL/NHL to begin with given prior disclosures as well as other PI3k debacles.

[zach @zbiotech]

Cortexyme Announces Clinical Hold on Atuzaginstat’s Investigational New Drug Application

$CRTX

[pharmacreep @pharmacreep]

$SRRA Clinically de-risked oncology drug in blockbuster indication with clear differentiation in area of unmet need. Stock is a bargain here. Should be $1B EV at least.